Med Updates #1
Med Updates #1
Recent research trial shows evidence that a cure may be possible for deadly peanut allergy! Murdoch Children’s Research Institute recently revealed that a clinical trial currently being performed has still shown long lasting effects for a treatment of peanut allergy. At the conclusion of one trial in 2013, 82% of children receiving the probiotic and peanut oral immunotherapy (PPOIT) were found to tolerate consumption of peanuts. Four years after this, those children are still eating peanuts! 80% eat peanuts as a normal part of diet and 70% have confirmed via a challenge test a long-term tolerance.
This study could radically change the face of modern food allergies. Peanuts, as the most deadly and most common cause of anaphylaxis, have been research without progress for quite a long time. Professor Mimi Tang, the PPOIT treatment, administered either a placebo once daily for 18 months or the probiotic, Lactobacillus rhamnosus along with an increasing amount of peanut protein. The groups, respectively, demonstrated less than 4% and over 80% tolerance to peanuts. Prof Tang says, “It also suggests the exciting possibility that tolerance is a realistic target for treating food allergy. This is a major step forward in identifying an effective treatment to address the food allergy problem in Western societies.” And she’s right. A biotech company, Prota Therapeutics, was brought on by MCRI and OneVentures to obtain a FDA approved product so global use can be implemented. If this study is confirmed in a Phase III study, we could see a shift in the way peanut allergy is managed and treated.